ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Embolic Agents Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-23S9331
Home | Market Reports | Health| Medical Devices & Equipment
Global Embolic Agents Market Insights and Forecast to 2028
BUY CHAPTERS

Global Embolic Agents Market Research Report 2025

Code: QYRE-Auto-23S9331
Report
August 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Terumo
Boston Scientific
Merit Medical
Johnson & Johnson
GEM Italy
IMBiotechnologies Ltd（IMB）
Emboflu
BTG Plc
Cook Medical

Embolic Agents Market

The global market for Embolic Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Embolic Agent is a material used to block off blood flow through a vessel.
North American market for Embolic Agents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Embolic Agents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Embolic Agents include Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd（IMB）, Emboflu, BTG, Cook Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Embolic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolic Agents.
The Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Embolic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Embolic Agents Market Report

Report Metric Details
Report Name Embolic Agents Market
Segment by Type
  • Liquid Embolic Agents
  • Particulate Embolic Agents
  • Others
Segment by Application
  • Occlude Bleeding
  • Oncotherapy
  • Malignant Hypertension
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd（IMB）, Emboflu, BTG, Cook Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Embolic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Embolic Agents Market report?

Ans: The main players in the Embolic Agents Market are Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd（IMB）, Emboflu, BTG, Cook Medical

What are the Application segmentation covered in the Embolic Agents Market report?

Ans: The Applications covered in the Embolic Agents Market report are Occlude Bleeding, Oncotherapy, Malignant Hypertension, Others

What are the Type segmentation covered in the Embolic Agents Market report?

Ans: The Types covered in the Embolic Agents Market report are Liquid Embolic Agents, Particulate Embolic Agents, Others

1 Embolic Agents Market Overview
1.1 Product Definition
1.2 Embolic Agents by Type
1.2.1 Global Embolic Agents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liquid Embolic Agents
1.2.3 Particulate Embolic Agents
1.2.4 Others
1.3 Embolic Agents by Application
1.3.1 Global Embolic Agents Market Value by Application (2024 VS 2031)
1.3.2 Occlude Bleeding
1.3.3 Oncotherapy
1.3.4 Malignant Hypertension
1.3.5 Others
1.4 Global Embolic Agents Market Size Estimates and Forecasts
1.4.1 Global Embolic Agents Revenue 2020-2031
1.4.2 Global Embolic Agents Sales 2020-2031
1.4.3 Global Embolic Agents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Embolic Agents Market Competition by Manufacturers
2.1 Global Embolic Agents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Embolic Agents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Embolic Agents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Embolic Agents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Embolic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Embolic Agents, Product Type & Application
2.7 Global Key Manufacturers of Embolic Agents, Date of Enter into This Industry
2.8 Global Embolic Agents Market Competitive Situation and Trends
2.8.1 Global Embolic Agents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Embolic Agents Players Market Share by Revenue
2.8.3 Global Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Embolic Agents Market Scenario by Region
3.1 Global Embolic Agents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Embolic Agents Sales by Region: 2020-2031
3.2.1 Global Embolic Agents Sales by Region: 2020-2025
3.2.2 Global Embolic Agents Sales by Region: 2026-2031
3.3 Global Embolic Agents Revenue by Region: 2020-2031
3.3.1 Global Embolic Agents Revenue by Region: 2020-2025
3.3.2 Global Embolic Agents Revenue by Region: 2026-2031
3.4 North America Embolic Agents Market Facts & Figures by Country
3.4.1 North America Embolic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Embolic Agents Sales by Country (2020-2031)
3.4.3 North America Embolic Agents Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolic Agents Market Facts & Figures by Country
3.5.1 Europe Embolic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Embolic Agents Sales by Country (2020-2031)
3.5.3 Europe Embolic Agents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolic Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Embolic Agents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Embolic Agents Sales by Region (2020-2031)
3.6.3 Asia Pacific Embolic Agents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolic Agents Market Facts & Figures by Country
3.7.1 Latin America Embolic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Embolic Agents Sales by Country (2020-2031)
3.7.3 Latin America Embolic Agents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolic Agents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Embolic Agents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Embolic Agents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolic Agents Sales by Type (2020-2031)
4.1.1 Global Embolic Agents Sales by Type (2020-2025)
4.1.2 Global Embolic Agents Sales by Type (2026-2031)
4.1.3 Global Embolic Agents Sales Market Share by Type (2020-2031)
4.2 Global Embolic Agents Revenue by Type (2020-2031)
4.2.1 Global Embolic Agents Revenue by Type (2020-2025)
4.2.2 Global Embolic Agents Revenue by Type (2026-2031)
4.2.3 Global Embolic Agents Revenue Market Share by Type (2020-2031)
4.3 Global Embolic Agents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Embolic Agents Sales by Application (2020-2031)
5.1.1 Global Embolic Agents Sales by Application (2020-2025)
5.1.2 Global Embolic Agents Sales by Application (2026-2031)
5.1.3 Global Embolic Agents Sales Market Share by Application (2020-2031)
5.2 Global Embolic Agents Revenue by Application (2020-2031)
5.2.1 Global Embolic Agents Revenue by Application (2020-2025)
5.2.2 Global Embolic Agents Revenue by Application (2026-2031)
5.2.3 Global Embolic Agents Revenue Market Share by Application (2020-2031)
5.3 Global Embolic Agents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Embolic Agents Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Terumo Embolic Agents Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Company Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boston Scientific Embolic Agents Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Merit Medical
6.4.1 Merit Medical Company Information
6.4.2 Merit Medical Description and Business Overview
6.4.3 Merit Medical Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merit Medical Embolic Agents Product Portfolio
6.4.5 Merit Medical Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Embolic Agents Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 GEM Italy
6.6.1 GEM Italy Company Information
6.6.2 GEM Italy Description and Business Overview
6.6.3 GEM Italy Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GEM Italy Embolic Agents Product Portfolio
6.6.5 GEM Italy Recent Developments/Updates
6.7 IMBiotechnologies Ltd（IMB）
6.7.1 IMBiotechnologies Ltd（IMB） Company Information
6.7.2 IMBiotechnologies Ltd（IMB） Description and Business Overview
6.7.3 IMBiotechnologies Ltd（IMB） Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 IMBiotechnologies Ltd（IMB） Embolic Agents Product Portfolio
6.7.5 IMBiotechnologies Ltd（IMB） Recent Developments/Updates
6.8 Emboflu
6.8.1 Emboflu Company Information
6.8.2 Emboflu Description and Business Overview
6.8.3 Emboflu Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Emboflu Embolic Agents Product Portfolio
6.8.5 Emboflu Recent Developments/Updates
6.9 BTG
6.9.1 BTG Company Information
6.9.2 BTG Description and Business Overview
6.9.3 BTG Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BTG Embolic Agents Product Portfolio
6.9.5 BTG Recent Developments/Updates
6.10 Cook Medical
6.10.1 Cook Medical Company Information
6.10.2 Cook Medical Description and Business Overview
6.10.3 Cook Medical Embolic Agents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cook Medical Embolic Agents Product Portfolio
6.10.5 Cook Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolic Agents Industry Chain Analysis
7.2 Embolic Agents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolic Agents Production Mode & Process Analysis
7.4 Embolic Agents Sales and Marketing
7.4.1 Embolic Agents Sales Channels
7.4.2 Embolic Agents Distributors
7.5 Embolic Agents Customer Analysis
8 Embolic Agents Market Dynamics
8.1 Embolic Agents Industry Trends
8.2 Embolic Agents Market Drivers
8.3 Embolic Agents Market Challenges
8.4 Embolic Agents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Medtronic Inc
Terumo
Boston Scientific
Merit Medical
Johnson & Johnson
GEM Italy
IMBiotechnologies Ltd（IMB）
Emboflu
BTG Plc
Cook Medical
List of Tables
 Table 1. Global Embolic Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Embolic Agents Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Embolic Agents Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Embolic Agents Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Embolic Agents Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Embolic Agents Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Embolic Agents Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Embolic Agents Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Embolic Agents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Embolic Agents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Embolic Agents, Product Type & Application
 Table 12. Global Key Manufacturers of Embolic Agents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Embolic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolic Agents as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Embolic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Embolic Agents Sales by Region (2020-2025) & (K Units)
 Table 18. Global Embolic Agents Sales Market Share by Region (2020-2025)
 Table 19. Global Embolic Agents Sales by Region (2026-2031) & (K Units)
 Table 20. Global Embolic Agents Sales Market Share by Region (2026-2031)
 Table 21. Global Embolic Agents Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Embolic Agents Revenue Market Share by Region (2020-2025)
 Table 23. Global Embolic Agents Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Embolic Agents Revenue Market Share by Region (2026-2031)
 Table 25. North America Embolic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Embolic Agents Sales by Country (2020-2025) & (K Units)
 Table 27. North America Embolic Agents Sales by Country (2026-2031) & (K Units)
 Table 28. North America Embolic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Embolic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Embolic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Embolic Agents Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Embolic Agents Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Embolic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Embolic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Embolic Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Embolic Agents Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Embolic Agents Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Embolic Agents Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Embolic Agents Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Embolic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Embolic Agents Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Embolic Agents Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Embolic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Embolic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Embolic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Embolic Agents Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Embolic Agents Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Embolic Agents Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Embolic Agents Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Embolic Agents Sales (K Units) by Type (2020-2025)
 Table 51. Global Embolic Agents Sales (K Units) by Type (2026-2031)
 Table 52. Global Embolic Agents Sales Market Share by Type (2020-2025)
 Table 53. Global Embolic Agents Sales Market Share by Type (2026-2031)
 Table 54. Global Embolic Agents Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Embolic Agents Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Embolic Agents Revenue Market Share by Type (2020-2025)
 Table 57. Global Embolic Agents Revenue Market Share by Type (2026-2031)
 Table 58. Global Embolic Agents Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Embolic Agents Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Embolic Agents Sales (K Units) by Application (2020-2025)
 Table 61. Global Embolic Agents Sales (K Units) by Application (2026-2031)
 Table 62. Global Embolic Agents Sales Market Share by Application (2020-2025)
 Table 63. Global Embolic Agents Sales Market Share by Application (2026-2031)
 Table 64. Global Embolic Agents Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Embolic Agents Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Embolic Agents Revenue Market Share by Application (2020-2025)
 Table 67. Global Embolic Agents Revenue Market Share by Application (2026-2031)
 Table 68. Global Embolic Agents Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Embolic Agents Price (USD/Unit) by Application (2026-2031)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic Embolic Agents Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Terumo Company Information
 Table 76. Terumo Description and Business Overview
 Table 77. Terumo Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Terumo Embolic Agents Product
 Table 79. Terumo Recent Developments/Updates
 Table 80. Boston Scientific Company Information
 Table 81. Boston Scientific Description and Business Overview
 Table 82. Boston Scientific Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Boston Scientific Embolic Agents Product
 Table 84. Boston Scientific Recent Developments/Updates
 Table 85. Merit Medical Company Information
 Table 86. Merit Medical Description and Business Overview
 Table 87. Merit Medical Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Merit Medical Embolic Agents Product
 Table 89. Merit Medical Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Johnson & Johnson Embolic Agents Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. GEM Italy Company Information
 Table 96. GEM Italy Description and Business Overview
 Table 97. GEM Italy Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. GEM Italy Embolic Agents Product
 Table 99. GEM Italy Recent Developments/Updates
 Table 100. IMBiotechnologies Ltd（IMB） Company Information
 Table 101. IMBiotechnologies Ltd（IMB） Description and Business Overview
 Table 102. IMBiotechnologies Ltd（IMB） Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. IMBiotechnologies Ltd（IMB） Embolic Agents Product
 Table 104. IMBiotechnologies Ltd（IMB） Recent Developments/Updates
 Table 105. Emboflu Company Information
 Table 106. Emboflu Description and Business Overview
 Table 107. Emboflu Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Emboflu Embolic Agents Product
 Table 109. Emboflu Recent Developments/Updates
 Table 110. BTG Company Information
 Table 111. BTG Description and Business Overview
 Table 112. BTG Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. BTG Embolic Agents Product
 Table 114. BTG Recent Developments/Updates
 Table 115. Cook Medical Company Information
 Table 116. Cook Medical Description and Business Overview
 Table 117. Cook Medical Embolic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Cook Medical Embolic Agents Product
 Table 119. Cook Medical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Embolic Agents Distributors List
 Table 123. Embolic Agents Customers List
 Table 124. Embolic Agents Market Trends
 Table 125. Embolic Agents Market Drivers
 Table 126. Embolic Agents Market Challenges
 Table 127. Embolic Agents Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Embolic Agents
 Figure 2. Global Embolic Agents Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Embolic Agents Market Share by Type: 2024 & 2031
 Figure 4. Liquid Embolic Agents Product Picture
 Figure 5. Particulate Embolic Agents Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Embolic Agents Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Embolic Agents Market Share by Application: 2024 & 2031
 Figure 9. Occlude Bleeding
 Figure 10. Oncotherapy
 Figure 11. Malignant Hypertension
 Figure 12. Others
 Figure 13. Global Embolic Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Embolic Agents Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Embolic Agents Sales (2020-2031) & (K Units)
 Figure 16. Global Embolic Agents Average Price (USD/Unit) & (2020-2031)
 Figure 17. Embolic Agents Report Years Considered
 Figure 18. Embolic Agents Sales Share by Manufacturers in 2024
 Figure 19. Global Embolic Agents Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Embolic Agents Players: Market Share by Revenue in Embolic Agents in 2024
 Figure 21. Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Embolic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Embolic Agents Sales Market Share by Country (2020-2031)
 Figure 24. North America Embolic Agents Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Embolic Agents Sales Market Share by Country (2020-2031)
 Figure 28. Europe Embolic Agents Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Embolic Agents Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Embolic Agents Revenue Market Share by Region (2020-2031)
 Figure 36. China Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Embolic Agents Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Embolic Agents Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Embolic Agents Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Embolic Agents Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Embolic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Embolic Agents by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Embolic Agents by Type (2020-2031)
 Figure 58. Global Embolic Agents Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Embolic Agents by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Embolic Agents by Application (2020-2031)
 Figure 61. Global Embolic Agents Price (USD/Unit) by Application (2020-2031)
 Figure 62. Embolic Agents Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Blood Vessels Embolic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liquid Embolic Agent Market Research Report 2025
Global Embolic Microspheres Market Insights Forecast to 2030
Vascular Embolization Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liquid Embolic Materials Market Research Report 2024
Global Liquid Embolic Device Market Research Report 2025
Global Embolic Prevention Systems Market Research Report 2024
Global Embolic Filters Market Insights Forecast to 2030
Global Peripheral Embolization Devices Market Research Report 2024
Global Embolization Spheres Market Research Report 2024
Global Peripheral Liquid Embolic Agents Market Research Report 2024
Global Embolic Coil System Market Research Report 2025
Global Embolization Coil System Market Research Report 2024
Global Embolic Protection Systems Market Research Report 2024
Global Interventional X ray Contrast and Imaging Agents Market Insights Forecast to 2030
Embolization Devices Market
Global Coronary Embolic Protection Device Market Research Report 2024
Cardiovascular Embolic Protection Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adhesive Liquid Embolic Materials Market Research Report 2024
Hydrogel Embolic Coil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions